BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 20444901)

  • 1. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
    Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
    J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.
    Macaire H; Riquet A; Moncollin V; Biémont-Trescol MC; Duc Dodon M; Hermine O; Debaud AL; Mahieux R; Mesnard JM; Pierre M; Gazzolo L; Bonnefoy N; Valentin H
    J Biol Chem; 2012 Jun; 287(25):21357-70. PubMed ID: 22553204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels.
    Bogenberger JM; Laybourn PJ
    Retrovirology; 2008 Jan; 5():9. PubMed ID: 18237376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2.
    de La Fuente C; Santiago F; Chong SY; Deng L; Mayhood T; Fu P; Stein D; Denny T; Coffman F; Azimi N; Mahieux R; Kashanchi F
    J Virol; 2000 Aug; 74(16):7270-83. PubMed ID: 10906181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of parathyroid hormone-related protein promoter P3 by ETS-1 in adult T-cell leukemia/lymphoma.
    Richard V; Nadella MV; Green PL; Lairmore MD; Feuer G; Foley JG; Rosol TJ
    Leukemia; 2005 Jul; 19(7):1175-83. PubMed ID: 15889157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tax contributes apoptosis resistance to HTLV-1-infected T cells via suppression of Bid and Bim expression.
    Mühleisen A; Giaisi M; Köhler R; Krammer PH; Li-Weber M
    Cell Death Dis; 2014 Dec; 5(12):e1575. PubMed ID: 25522269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of proapoptotic Bim augments IL-2-independent T-cell transformation by human T-cell leukemia virus type-1 Tax.
    Higuchi M; Takahashi M; Tanaka Y; Fujii M
    Cancer Med; 2014 Dec; 3(6):1605-14. PubMed ID: 25175936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insight into the study of adult T-cell leukemia/lymphoma (ATLL): Ten-year studies on HTLV-1 associated diseases in an endemic region.
    Ashrafi F; Rahimzada M; Parandi M; Mirhosseini A; Mashkani B; Ahmadi Ghezeldasht S; Soltani A; Rafatpanah H; Mosavat A; Abdolrahim Rezaee S
    Gene; 2022 Dec; 847():146885. PubMed ID: 36108787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.
    Kress AK; Schneider G; Pichler K; Kalmer M; Fleckenstein B; Grassmann R
    J Virol; 2010 Sep; 84(17):8732-42. PubMed ID: 20573814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-1 Tax-specific memory cytotoxic T lymphocytes in long-term survivors of aggressive-type adult T-cell leukemia/lymphoma.
    Jo T; Noguchi K; Sakai T; Kubota-Koketsu R; Irie S; Matsuo M; Taguchi J; Abe K; Shigematsu K
    Cancer Med; 2022 Sep; 11(17):3238-3250. PubMed ID: 35315593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
    Ohshima K
    Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival.
    Panfil AR; Al-Saleem J; Howard CM; Mates JM; Kwiek JJ; Baiocchi RA; Green PL
    Viruses; 2015 Dec; 8(1):. PubMed ID: 26729154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
    Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
    Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
    Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
    Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of NDRG2 expression during ATLL development after HTLV-1 infection.
    Ichikawa T; Nakahata S; Fujii M; Iha H; Shimoda K; Morishita K
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2633-2646. PubMed ID: 31295529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of DOK1, 2, and 3 genes in HTLV-1-infected T cells.
    Ohsugi T; Wakamiya M; Morikawa S; Fujita M
    Acta Virol; 2016 Jun; 60(2):211-3. PubMed ID: 27265473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latency Reversing Agents: Kick and Kill of HTLV-1?
    Schnell AP; Kohrt S; Thoma-Kress AK
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.
    Rauch DA; Ratner L
    Viruses; 2011 Jun; 3(6):886-900. PubMed ID: 21994759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rigosertib is more potent than wortmannin and rapamycin against adult T-cell leukemia-lymphoma.
    Ghorbanzadeh Neghab M; Jalili-Nik M; Soltani A; Afshari AR; Hassanian SM; Rafatpanah H; Rezaee SA; Sadeghnia HR; Ataei Azimi S; Mashkani B
    Biofactors; 2023; 49(6):1174-1188. PubMed ID: 37345860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 dysfunction precedes the activation of nuclear factor-κB during disease progression in mice expressing Tax, a human T-cell leukemia virus type 1 oncoprotein.
    Ohsugi T; Ishida T; Shimasaki T; Okada S; Umezawa K
    Carcinogenesis; 2013 Sep; 34(9):2129-36. PubMed ID: 23633516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.